BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23572153)

  • 1. Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.
    MacCallum DM; Desbois AP; Coote PJ
    Eur J Clin Microbiol Infect Dis; 2013 Aug; 32(8):1055-62. PubMed ID: 23572153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of caspofungin or anidulafungin with antimicrobial peptides results in potent synergistic killing of Candida albicans and Candida glabrata in vitro.
    Harris MR; Coote PJ
    Int J Antimicrob Agents; 2010 Apr; 35(4):347-56. PubMed ID: 20106636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of antifungal combinations against Candida albicans biofilms.
    Tobudic S; Kratzer C; Lassnigg A; Graninger W; Presterl E
    J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
    Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
    J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin interacts synergistically with echinocandins against Candida auris.
    Bidaud AL; Djenontin E; Botterel F; Chowdhary A; Dannaoui E
    Int J Antimicrob Agents; 2020 Mar; 55(3):105901. PubMed ID: 31954831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacies of caspofungin and a combination of caspofungin and meropenem in the treatment of murine disseminated candidiasis.
    Ozcan SK; Budak F; Willke A; Filiz S; Costur P; Dalcik H
    APMIS; 2006 Dec; 114(12):829-36. PubMed ID: 17207082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans.
    Chen YL; Lehman VN; Averette AF; Perfect JR; Heitman J
    PLoS One; 2013; 8(3):e57672. PubMed ID: 23472097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of the tyrocidines, antimicrobial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin B and caspofungin against Candida albicans biofilms.
    Troskie AM; Rautenbach M; Delattin N; Vosloo JA; Dathe M; Cammue BP; Thevissen K
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3697-707. PubMed ID: 24752256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis.
    Hernandez S; López-Ribot JL; Najvar LK; McCarthy DI; Bocanegra R; Graybill JR
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1382-3. PubMed ID: 15047549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms.
    Delattin N; De Brucker K; Vandamme K; Meert E; Marchand A; Chaltin P; Cammue BP; Thevissen K
    J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
    Wheeler RT; Kombe D; Agarwala SD; Fink GR
    PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis.
    Farzanegan A; Roudbary M; Falahati M; Khoobi M; Gholibegloo E; Farahyar S; Karimi P; Khanmohammadi M
    J Mycol Med; 2018 Dec; 28(4):628-636. PubMed ID: 30126717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
    Wang Y; Lu C; Zhao X; Wang D; Liu Y; Sun S
    Biomed Pharmacother; 2021 Jul; 139():111568. PubMed ID: 33845374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.
    Arendrup MC; Garcia-Effron G; Buzina W; Mortensen KL; Reiter N; Lundin C; Jensen HE; Lass-Flörl C; Perlin DS; Bruun B
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1185-93. PubMed ID: 19104024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of novel synthetic dodecapeptides against Candida albicans.
    Maurya IK; Thota CK; Sharma J; Tupe SG; Chaudhary P; Singh MK; Thakur IS; Deshpande M; Prasad R; Chauhan VS
    Biochim Biophys Acta; 2013 Nov; 1830(11):5193-203. PubMed ID: 23876294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
    Shinde RB; Chauhan NM; Raut JS; Karuppayil SM
    Ann Clin Microbiol Antimicrob; 2012 Oct; 11():27. PubMed ID: 23035934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
    Rueda C; Cuenca-Estrella M; Zaragoza O
    Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the
    Cheung YY; Hui M
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
    Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.